Guangdong Raynovent Biotech Co., Ltd
Guangdong Raynovent Biotech Co., Ltd
Explore linked clinical trials.11 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of the Bioequivalence of RAY1225 Injection in Healthy Participants | Basic Science | Not yet recruiting | Phase 1 | 2026-09-18 | NCT07827027 | |
| A Mass Balance Study Of 14C-RAY1225 Injection In Healthy Chinese Participants | Basic Science | Not yet recruiting | Phase 1 | 2026-03-10 | NCT07460284 | |
| Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 1 | 2026-01-23 | NCT07362030 | |
| Efficacy and Safety of ZSP1273 in Children 12-17 Years Old With Influenza A | Influenza A | Active, not recruiting | Phase 3 | 2025-12-16 | NCT07229820 | |
| Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza A | Influenza a | Active, not recruiting | Phase 3 | 2025-12-16 | NCT07229807 | |
| A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 Diabetes | type 2 diabetes mellitus | Not yet recruiting | Phase 3 | 2025-08-24 | NCT07139548 | |
| A Study of RAY1225 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone | type 2 diabetes mellitus | Not yet recruiting | Phase 3 | 2025-08-24 | NCT07139535 | |
| A Study of RAY1225 in Participants With Type 2 Diabetes | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Active, not recruiting | Phase 2 | 2025-08-05 | NCT06254274 | |
| Evaluation of RAY1225 in Adult Participants Who Have Obesity or Are Overweight | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 3 | 2025-07-17 | NCT06893016 | |
| A Study of RAY1225 in Participants With Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 2 | 2025-03-19 | NCT06254261 | |
| A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH) | Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease | Active, not recruiting | Phase 2 | 2025-03-19 | NCT05692492 |